Shares of Regencell Bioscience Holdings Limited (RGC) have been firing on all cylinders since March 13, 2025, following the release of an SEC filing that day.
The filing revealed that on March 10, 2025, Regencell (BVI) Limited, acting as the buyer, entered into a Sale and Purchase Agreement with a third-party shareholder of the company, the seller. Under the terms of the agreement, Regencell (BVI) Limited agreed to acquire 652,982 ordinary shares from the seller for a total of $6.2 million or $9.50 per share, subject to the agreed-upon terms and conditions. The buyback was funded by Yat-Gai Au, the CEO of Regencell.
For comments and feedback contact: editorial@rttnews.com
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.